Status:

RECRUITING

Elimination of Odor and Treatment of Malodorous Recalcitrant Wounds by Using Supraz and PRP-FG Versus Standard of Care

Lead Sponsor:

Mashhad University of Medical Sciences

Collaborating Sponsors:

Aristotle University Of Thessaloniki

Conditions:

Wounds and Injuries

Eligibility:

All Genders

Phase:

PHASE2

PHASE3

Brief Summary

The aim of this study is to eliminate the malodorous of chronic wound and increase the chance of the healing of recalcitrant wounds by using the repairing gel (supraz gel) which has the approved compo...

Detailed Description

The current study assesses the effects of platelet-rich plasma-fibrin glue (PRP-FG) along with the use of the repairing gel which has the approved components on wound healing in patients with chronic ...

Eligibility Criteria

Inclusion

  • Having a single wound on the body that has been at least 3 months old and has not been repaired by wound irrigation with normal saline and changing the dressing
  • Having a body mass index of 18-35
  • Sign the informed consent by the patient

Exclusion

  • Having concurrent diseases that may cause problems in wound healing, such as cancers, vasculitis, kidney and liver failure, and heart failure
  • Taking certain drugs that may interfere with wound healing, such as corticosteroids, immunosuppressive agents, and cytotoxic agents

Key Trial Info

Start Date :

August 20 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 20 2024

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT05983302

Start Date

August 20 2023

End Date

March 20 2024

Last Update

March 26 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Medical School, Aristotle University of Thessaloniki

Thessaloniki, Greece

2

Mashhad University of Medical Sciences

Mashhad, Razavi Khorasan Province, Iran, 99191-91778